We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




HPV Tests Useful in ASCUS Cases

By HospiMedica staff writers
Posted on 26 Jan 2006
When a Pap test result is classified as atypical squamous cells of undetermined significance (ASCUS), a test for the human papillomarvirus (HPV) may be the best way to proceed, according to a new study reported in the January 18, 2006, issue of the Journal of the National Cancer Institute,

An HPV test would help a doctor to decide whether or not the patient should have more invasive testing. More...
Conservative management with additional testing or immediate colposcopy were both shown to be less cost-effective.

The study involved 3,488 women with ASCUS results, who were randomly assigned to colposcopy, HPV triage followed by colposcopy if an oncogenic virus was found, or conservative management based on repeating the Pap test, with a referral to colposcopy if the patient had high-grade intraepithelial lesions.

Although the least costly stratety turned out to be conservative management with only one repeat Pap test, this method was found to detect the fewest number of precancer cases. While adding additional tests improved detection, it was less cost-effective. An immediate referral of the patient for colposcopy was shown to be cost-effective only if that procedure and a subsequent biopsy were assumed to be 100% sensitive.

In contrast, testing for HPV was both lest costly and a better predictor of precancer and cancer cases than either conservative management or immediate colposcopy.

The researchers, from the Duke Center for Clinical Health Policy Research (Durham, NC, USA; www.dukehealth.org), said that using the same money to reduce health-case disparities and to extend screening to under-screened groups "might have a greater impact on cervical cancer mortality than applying those resources to HPV triage of ASCUS.”






Related Links:
Duke Center

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.